Ventyx Biosciences, Inc.
VTYX
$0.9146
$0.07859.39%
| Weiss Ratings | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.85 | |||
| Price History | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -24.41% | |||
| 30-Day Total Return | -39.83% | |||
| 60-Day Total Return | -56.03% | |||
| 90-Day Total Return | -55.60% | |||
| Year to Date Total Return | -57.26% | |||
| 1-Year Total Return | -80.62% | |||
| 2-Year Total Return | -96.80% | |||
| 3-Year Total Return | -92.99% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -85.23% | |||
| 52-Week Low % Change | 6.78% | |||
| Price | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.66 | |||
| 52-Week Low Price | $0.78 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Jun 05, 2024 | |||
| Valuation | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 59.47M | |||
| Enterprise Value | -182.68M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.99 | |||
| Earnings Per Share Growth | -39.59% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.23 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.91 | |||
| Enterprise Value/EBITDA (TTM) | 1.23 | |||
| Enterprise Value/EBIT | 1.23 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 70.81M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 760 593 4832 | |||
| Address | 12790 El Camino Real San Diego, CA 92130 | |||
| Website | ventyxbio.com | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -33.48% | |||
| Return on Equity | -- | |||
| Income Statement | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -148.18M | |||
| EBIT (TTM) | -148.45M | |||
| Net Income (TTM) | -135.12M | |||
| Net Income Avl. to Common (TTM) | -135.12M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 37.22% | |||
| EPS Diluted (TTM) | -1.99 | |||
| EPS Diluted Growth (Q YOY) | 47.62% | |||
| Balance Sheet | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 217.32M | |||
| Cash Per Share (Q) | $3.07 | |||
| Total Current Assets (Q) | 229.63M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 254.05M | |||
| Current Ratio (Q) | 17.973 | |||
| Book Value Per Share (Q) | $3.57 | |||
| Total Assets (Q) | 276.56M | |||
| Total Current Liabilities (Q) | 12.78M | |||
| Total Debt (Q) | 10.79M | |||
| Total Liabilities (Q) | 22.52M | |||
| Total Common Equity (Q) | 254.05M | |||
| Cash Flow | VTYX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -15.51M | |||
| Cash from Financing (TTM) | 122.12M | |||
| Net Change in Cash (TTM) | -24.32M | |||
| Levered Free Cash Flow (TTM) | -78.46M | |||
| Cash from Operations (TTM) | -130.87M | |||
